NCT06634485Not yet recruiting
Spirometry ,diaphragmatic Ultrasound and Skeletal Muscle Mass in Patients with Chronic Obstructive Pulmonary Disease
Correlation Between Spirometry ,diaphragmatic Ultrasound and Skeletal Muscle Mass in Patients with Chronic Obstructive Pulmonary Disease : Case Control Study
Source: ClinicalTrials.gov · Last updated 10 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
* The primary objective is to evaluate the use of diaphragmatic function and skeletal muscle mass by ultrasound as a tool to establish the diagnosis of COPD and assess the severity of the disease. * The secondary objective is to compare diaphragmatic function, Skeletal muscle mass, and spirometry results in patients with COPD.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 64 (estimated)
- First submitted
- 21 Aug 2024
- Start date
- 10 Oct 2024
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- Assiut University
- Diseases
- COPD
- NCT number
- NCT06634485
What you commit to
- Study type: Observational
- Planned participants: 64
- From 10 Oct 2024 to the primary completion date, 1 Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Group A (control group):
- Patients with disorders that may affect diaphragmatic function as
- Musculoskeletal / neurological disorders
- diaphragmatic eventration \\ hiatus hernia
- morbid obesity
- recent thoracic/abdominal surgeries
- pregnancy; pleurodesis \\fibrothorax.
- Group B (study group):-
- Patients need for non- invasive ventilation.
- Patients with disorders that may affect diaphragmatic function as
- Musculoskeletal / neurological disorders
- diaphragmatic eventration \\ hiatus hernia
- morbid obesity
- recent thoracic/abdominal surgeries
- pregnancy; pleurodesis \\fibrothorax
Who the study is looking for
- Group A (control group):
- This group include healthy volunteers who aged ≥ 40 years .
- Group B (study group):
- This include stable COPD Patients who will be diagnosed by GOLD 2024 and last excerbation ≥ 6weeks .
Age in the registry: 41 years to 70 years · Sex: Male · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.